other material
confidence high
sentiment negative
materiality 0.60
Organovo shareholders approve reverse stock split (1:5-1:20) and 1.78M share equity plan increase
VivoSim Labs, INC.
- Reverse stock split authorized at ratio 1-to-5 to 1-to-20, board discretion until Nov 20, 2025; 88.64% voted for.
- 2022 Equity Incentive Plan amended to add 1,775,000 shares; 89.41% approval.
- Class I directors Alison Tjosvold Milhous and Vaidehi Joshi elected with ~92.4% and ~93.9% of votes cast, respectively.
- Rosenberg Rich Baker Berman ratified as auditor for FY ending March 2025 (89.25% approval).
- Advisory vote on named executive officer compensation passed with 92.30% of votes cast.